Canaccord Adams Downgrades Dolby Laboratories (DLB) to Hold

November 4, 2009 11:45 AM EST

Canaccord Adams downgrades Dolby Laboratories (NYSE: DLB) from Buy to Hold, following sales and earnings that beat estimates, but guidance that was below expectations.

Analyst Jeff Rath said, "Dolby at its current price level appears fully valued given the growth rates implied from guidance. We therefore downgrade to a HOLD and lower our price target to $44 (from $46), which implies a 16.5x P/E based on our 2010 non-GAAP estimate, plus cash."


Related Categories

Downgrades

Stocks Mentioned

DLB 43.98

+0.00 +0.00%
Volume: 317,744
Track DLB


Related Entities


Add Your Comment